MSD
For over 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of their mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A.
See below for the Latest MSD News, Analysis, Profit Results, Share Price Information, and Commentary.
MSD navigates the pandemic tapestry in COVID-19 fight
MSD navigates the pandemic tapestry in COVID-19 fight
It has navigated the complexities of the challenging period through a proactive approach.
Join the community
Most Read
1. Personalised medicine to drive 17% CAGR in healthcare 3D printing, $14.6b by 2033 2. Sunway Healthcare signs underwriting agreement ahead of 2026 IPO 3. India dental devices market grows on tech adoption 4. Gleneagles Hospital HK forms strategic partnership to advance venous disease care 5. Radiopharma market to hit $21.8b by 2033 on cancer therapy boomResource Center
Events
Event News
Healthcare Asia Summit 2026 in Singapore to highlight digital transformation, emerging health ecosystems
Top leaders will discuss AI adoption in healthcare.